High LDL levels are associated with increased lipoprotein-associated phospholipase A(2) activity on nitric oxide synthesis and reactive oxygen species formation in human endothelial cells

dc.contributor.author
Searle, Andrea
dc.contributor.author
Gómez Rosso, Leonardo
dc.contributor.author
Meroño, Tomás
dc.contributor.author
Salomon, Carlos
dc.contributor.author
Durán-Sandoval, Daniel
dc.contributor.author
Giunta, Gustavo
dc.contributor.author
Grant, Carlos
dc.contributor.author
Calvo, Carlos
dc.contributor.author
Lamperti, Liliana
dc.contributor.author
Brites, Fernando
dc.contributor.author
Aguayo, Claudio
dc.date.issued
2023-02-16T11:01:34Z
dc.date.issued
2023-02-16T11:01:34Z
dc.date.issued
2011-02-05
dc.date.issued
2023-02-16T11:01:34Z
dc.identifier
0009-9120
dc.identifier
https://hdl.handle.net/2445/193701
dc.identifier
728116
dc.description.abstract
Objective: To evaluate in vitro the effects of serum and LDL fractions isolated from hypercholesterolemic patients on nitric oxide (NO) synthesis and reactive oxygen species (ROS) production by human umbilical vein endothelial cells (HUVECs). Design and methods: Serum and LDL isolated from subjects with high (n=18) and normal (n=21) LDL-cholesterol levels were analyzed on NO synthesis and ROS production in vitro models of HUVECs. LDL was furthers characterized in their chemical composition and activities of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)), cholesteryl ester transfer protein (CETP) and paraoxonase. Results: NO bioavailability was significantly lower and ROS production higher in HUVECs incubated with serum samples from patients with high LDL-cholesterol levels in comparison to control subjects. Moreover, hypercholesterolemic patients presented higher CETP and Lp-PLA(2) activities than control subjects. LDL fractions isolated from patients and controls were not different in their chemical composition, Lp-PLA(2) activity, and their capacity to reduce NO synthesis and increase ROS production. Conclusion: Alterations of serum from hypercholesterolemic patients could be due to the increment in LDL concentration, main Lp-PLA(2) carrier, and not to LDL composition or intrinsic Lp-PLA(2) activity.
dc.format
7 p.
dc.format
application/pdf
dc.language
eng
dc.publisher
Elsevier B.V.
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.clinbiochem.2010.10.004
dc.relation
Clinical Biochemistry, 2011, vol. 44, num. 2, p. 171-177
dc.relation
https://doi.org/10.1016/j.clinbiochem.2010.10.004
dc.rights
(c) Elsevier B.V., 2011
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)
dc.subject
Lipoproteïnes
dc.subject
Colesterol
dc.subject
Malalties cardiovasculars
dc.subject
Lipoproteins
dc.subject
Cholesterol
dc.subject
Cardiovascular diseases
dc.title
High LDL levels are associated with increased lipoprotein-associated phospholipase A(2) activity on nitric oxide synthesis and reactive oxygen species formation in human endothelial cells
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)